How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy

Front Immunol. 2021 Nov 26:12:800242. doi: 10.3389/fimmu.2021.800242. eCollection 2021.

Abstract

The identification of the major target antigen phospholipase A2 receptor (PLA2R) in the majority of primary (idiopathic) cases of membranous nephropathy (MN) has been followed by the rapid identification of numerous minor antigens that appear to define phenotypically distinct forms of disease. This article serves to review all the known antigens that have been shown to localize to subepithelial deposits in MN, as well as the distinctive characteristics associated with each subtype of MN. We will also shed light on the novel proteomic approaches that have allowed identification of the most recent antigens. The paradigm of an antigen normally expressed on the podocyte cell surface leading to in-situ immune complex formation, complement activation, and subsequent podocyte injury will be discussed and challenged in light of the current repertoire of multiple MN antigens. Since disease phenotypes associated with each individual target antigens can often blur the distinction between primary and secondary disease, we encourage the use of antigen-based classification of membranous nephropathy.

Keywords: antigen; autoimmune profiling; epitope spreading; mass spectrometry; membranous lupus nephritis; membranous nephropathy; serologic testing.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Autoantigens / immunology*
  • Glomerulonephritis, Membranous / immunology*
  • Humans

Substances

  • Autoantigens